Sprint Bioscience AB's total assets for Q4 2025 were kr136.66M, an increase of 537.47% from the previous quarter. SE:SPRINT total liabilities were kr17.48M for the fiscal quarter, a 13.72% a decrease from the previous quarter. See a summary of the company’s assets, liabilities, and equity.